Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer.

Tan WS, Krimphove MJ, Cole AP, Marchese M, Berg S, Lipsitz SR, Löppenberg B, Nabi J, Abdollah F, Choueiri TK, Kibel AS, Sooriakumaran P, Trinh QD.

Clin Genitourin Cancer. 2019 Jun 19. pii: S1558-7673(19)30035-7. doi: 10.1016/j.clgc.2019.06.008. [Epub ahead of print]

PMID:
31303561
2.

A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer.

Ventimiglia E, Seisen T, Abdollah F, Briganti A, Fonteyne V, James N, Roach M 3rd, Thalmann GN, Touijer K, Chen RC, Cheng L.

Eur Urol Oncol. 2019 May;2(3):294-301. doi: 10.1016/j.euo.2019.02.001. Epub 2019 Mar 23. Review.

PMID:
31200844
3.

Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.

Nazzani S, Preisser F, Bandini M, Marchioni M, Tian Z, Soulières D, Montanari E, Ratti D, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI.

Eur Urol Oncol. 2018 Sep;1(4):346-351. doi: 10.1016/j.euo.2018.05.008. Epub 2018 May 31.

PMID:
31100257
4.

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA.

Hanna N, Trinh QD, Seisen T, Vetterlein MW, Sammon J, Preston MA, Lipsitz SR, Bellmunt J, Menon M, Choueiri TK, Abdollah F.

Eur Urol Oncol. 2018 May;1(1):83-90. doi: 10.1016/j.euo.2018.03.001. Epub 2018 May 15.

PMID:
31100232
5.

Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.

Abdollah F, Keeley J, Menon M.

N Engl J Med. 2019 Feb 21;380(8):793. doi: 10.1056/NEJMc1816590. No abstract available.

PMID:
30786197
6.

Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care Redesign.

Friedlander DF, von Landenberg N, Löppenberg B, Noldus J, Lipsitz SR, Cole AP, Abdollah F, Nguyen PL, Choueiri TK, Kibel AS, Trinh QD.

J Urol. 2019 Apr;201(4):728-734. doi: 10.1097/JU.0000000000000006.

PMID:
30633112
7.

Retzius-sparing robot-assisted radical prostatectomy.

Sood A, Abdollah F, Menon M.

BJU Int. 2019 Jan;123(1):7-8. doi: 10.1111/bju.14518. No abstract available.

PMID:
30565400
8.

Comparing Adjuvant vs Early-Salvage Radiotherapy After Radical Prostatectomy.

Abdollah F, Dalela D, Menon M.

JAMA Oncol. 2018 Nov 1;4(11):1618-1619. doi: 10.1001/jamaoncol.2018.3533. No abstract available.

PMID:
30422245
9.

Cytoreductive Nephrectomy: Assessing the Generalizability of the CARMENA Trial to Real-world National Cancer Data Base Cases.

Arora S, Sood A, Dalela D, Tang HJ, Patel A, Keeley J, Trinh QD, Rogers CG, Menon M, Abdollah F.

Eur Urol. 2019 Feb;75(2):352-353. doi: 10.1016/j.eururo.2018.10.054. Epub 2018 Nov 9. No abstract available.

PMID:
30420256
10.

Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study.

Bandini M, Nazzani S, Marchioni M, Preisser F, Tian Z, Moschini M, Abdollah F, Suardi N, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Feb;17(1):72-78.e4. doi: 10.1016/j.clgc.2018.09.011. Epub 2018 Sep 22.

PMID:
30342845
11.

The effect of race on survival after local therapy in metastatic prostate cancer patients.

Mazzone E, Bandini M, Preisser F, Nazzani S, Tian Z, Abdollah F, Soulieres D, Graefen M, Montorsi F, Shariat S, Saad F, Briganti A, Karakiewicz PI.

Can Urol Assoc J. 2019 Jun;13(6):175-181. doi: 10.5489/cuaj.5399.

12.

Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis.

Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Soulières D, Montanari E, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI.

Eur Urol Focus. 2018 Sep 25. pii: S2405-4569(18)30279-7. doi: 10.1016/j.euf.2018.09.007. [Epub ahead of print]

PMID:
30266210
13.

Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis.

Gild P, Wankowicz SA, Sood A, von Landenberg N, Friedlander DF, Alanee S, Chun FKH, Fisch M, Menon M, Trinh QD, Bellmunt J, Abdollah F.

Urol Oncol. 2018 Oct;36(10):469.e1-469.e11. doi: 10.1016/j.urolonc.2018.07.012. Epub 2018 Aug 20.

PMID:
30139659
14.

Endocrine, Sexual Function, and Infertility Side Effects of Immune Checkpoint Inhibitor Therapy for Genitourinary Cancers.

Sood A, Cole D, Abdollah F, Eilender B, Roumayah Z, Deebajah M, Dabaja A, Alanee S.

Curr Urol Rep. 2018 Jul 3;19(9):68. doi: 10.1007/s11934-018-0819-7. Review.

PMID:
29971696
15.

Robot-assisted radical prostatectomy and a parachute.

Sood A, Abdollah F, Menon M.

BJU Int. 2018 Jun;121(6):820-821. doi: 10.1111/bju.14357. No abstract available.

16.

Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.

Karnes RJ, Sharma V, Choeurng V, Ashab HA, Erho N, Alshalalfa M, Trock B, Ross A, Yousefi K, Tsai H, Zhao SG, Tosoian JJ, Haddad Z, Takhar M, Chang SL, Spratt DE, Abdollah F, Jenkins RB, Klein EA, Nguyen PL, Dicker AP, Den RB, Davicioni E, Feng FY, Lotan TL, Schaeffer EM.

Clin Cancer Res. 2018 Aug 15;24(16):3908-3916. doi: 10.1158/1078-0432.CCR-17-2745. Epub 2018 May 14.

17.

Oncological and functional efficacy of nephron-sparing surgery versus radical nephrectomy in renal cell carcinoma stages ≥cT1b: a single institution, matched analysis.

Veys R, Abdollah F, Briganti A, Albersen M, Poppel HV, Joniau S.

Cent European J Urol. 2018;71(1):48-57. doi: 10.5173/ceju.2017.1611. Epub 2017 Dec 22.

19.

Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection.

Abdollah F, Dalela D, Sood A, Keeley J, Alanee S, Briganti A, Montorsi F, Peabody JO, Menon M.

Eur Urol. 2018 Sep;74(3):253-256. doi: 10.1016/j.eururo.2018.04.017. Epub 2018 Apr 30.

PMID:
29720348
20.

A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma.

Nazzani S, Bandini M, Marchioni M, Preisser F, Tian Z, Soulières D, Montanari E, Motta G, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI.

Radiother Oncol. 2018 May;127(2):318-325. doi: 10.1016/j.radonc.2018.03.027. Epub 2018 Apr 6.

PMID:
29631934
21.

Reply by the Authors.

Vetterlein MW, Abdollah F.

Urology. 2018 Jun;116:232-233. doi: 10.1016/j.urology.2018.03.006. Epub 2018 Mar 20. No abstract available.

PMID:
29572057
22.

Utilization of pelvic lymph node dissection in patients undergoing robot-assisted radical prostatectomy in India versus the United States - A Vattikuti Collective Quality Initiative database analysis.

Abdollah F, Arora S, Jindal T, Gild P, Sood A, Yuvaraja TB, Ahlawat RK, Gupta NP, Bhandari M, Menon M.

Indian J Cancer. 2017 Apr-Jun;54(2):421-425. doi: 10.4103/ijc.IJC_227_17.

23.

Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.

Marchioni M, Preisser F, Bandini M, Nazzani S, Tian Z, Kapoor A, Cindolo L, Abdollah F, Tilki D, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI.

Eur Urol Focus. 2018 Feb 2. pii: S2405-4569(18)30008-7. doi: 10.1016/j.euf.2018.01.007. [Epub ahead of print]

PMID:
29398456
24.

Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients.

Bandini M, Preisser F, Nazzani S, Marchioni M, Tian Z, Fossati N, Gandaglia G, Gallina A, Abdollah F, Shariat SF, Montorsi F, Saad F, Tilki D, Briganti A, Karakiewicz PI.

Eur Urol Focus. 2018 Jan 20. pii: S2405-4569(18)30010-5. doi: 10.1016/j.euf.2018.01.009. [Epub ahead of print]

PMID:
29366856
25.

The Impact of Lymph Node Metastases Burden at Radical Prostatectomy.

Preisser F, Marchioni M, Nazzani S, Bandini M, Tian Z, Pompe RS, Montorsi F, Saad F, Abdollah F, Steuber T, Heinzer H, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2018 Jan 3. pii: S2405-4569(17)30296-1. doi: 10.1016/j.euf.2017.12.009. [Epub ahead of print]

PMID:
29306731
26.

Re: Stenting prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence: B. Kiss, M. A. Furrer, P. Y. Wuethrich, F. C. Burkhard, G. N. Thalmann and B. Roth J Urol 2017;198:1263-1268.

Sood A, Abdollah F, Cole D, Alanee S.

J Urol. 2018 Apr;199(4):1069-1070. doi: 10.1016/j.juro.2017.11.119. Epub 2018 Jan 3. No abstract available.

PMID:
29305838
27.

Comparative effectiveness of robot-assisted vs. open radical cystectomy.

Hanna N, Leow JJ, Sun M, Friedlander DF, Seisen T, Abdollah F, Lipsitz SR, Menon M, Kibel AS, Bellmunt J, Choueiri TK, Trinh QD.

Urol Oncol. 2018 Mar;36(3):88.e1-88.e9. doi: 10.1016/j.urolonc.2017.09.018. Epub 2017 Dec 23.

PMID:
29277584
28.

Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy.

Spratt DE, Dai DLY, Den RB, Troncoso P, Yousefi K, Ross AE, Schaeffer EM, Haddad Z, Davicioni E, Mehra R, Morgan TM, Rayford W, Abdollah F, Trabulsi E, Achim M, Tapia ELN, Guerrero M, Karnes RJ, Dicker AP, Hurwitz MA, Nguyen PL, Feng FFY, Freedland SJ, Davis JW.

Eur Urol. 2018 Jul;74(1):107-114. doi: 10.1016/j.eururo.2017.11.024. Epub 2017 Dec 10.

29.

Functional Recovery, Oncologic Outcomes and Postoperative Complications after Robot-Assisted Radical Prostatectomy: An Evidence-Based Analysis Comparing the Retzius Sparing and Standard Approaches.

Menon M, Dalela D, Jamil M, Diaz M, Tallman C, Abdollah F, Sood A, Lehtola L, Miller D, Jeong W.

J Urol. 2018 May;199(5):1210-1217. doi: 10.1016/j.juro.2017.11.115. Epub 2017 Dec 7.

PMID:
29225060
30.

Reply.

Vetterlein MW, Sammon JD, Abdollah F.

Urology. 2018 Feb;112:64-65. doi: 10.1016/j.urology.2017.08.058. Epub 2017 Nov 27. No abstract available.

PMID:
29191382
31.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL.

J Clin Oncol. 2018 Feb 20;36(6):581-590. doi: 10.1200/JCO.2017.74.2940. Epub 2017 Nov 29.

32.

Re: Follow-up of Prostatectomy Versus Observation for Early Prostate Cancer.

Abdollah F, Dalela D, Menon M.

Eur Urol. 2018 Feb;73(2):302-303. doi: 10.1016/j.eururo.2017.11.009. Epub 2017 Nov 23. No abstract available.

PMID:
29174482
33.

First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy.

Bandini M, Marchioni M, Pompe RS, Tian Z, Gandaglia G, Fossati N, Abdollah F, Graefen M, Montorsi F, Saad F, Shariat SF, Briganti A, Karakiewicz PI.

BJU Int. 2018 Apr;121(4):592-599. doi: 10.1111/bju.14074. Epub 2017 Nov 29.

34.

Rate and Extent of Pelvic Lymph Node Dissection in the US Prostate Cancer Patients Treated With Radical Prostatectomy.

Nocera L, Sood A, Dalela D, Gild P, Rogers CG, Peabody JO, Montorsi F, Menon M, Briganti A, Abdollah F.

Clin Genitourin Cancer. 2018 Apr;16(2):e451-e467. doi: 10.1016/j.clgc.2017.10.003. Epub 2017 Oct 16.

PMID:
29113771
35.

State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update.

Vetterlein MW, Dalela D, Sammon JD, Karabon P, Sood A, Jindal T, Meyer CP, Löppenberg B, Sun M, Trinh QD, Menon M, Abdollah F.

Urology. 2018 Feb;112:56-65. doi: 10.1016/j.urology.2017.08.055. Epub 2017 Oct 19.

PMID:
29056579
36.

The Association between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer.

Ryan S, Serrell EC, Karabon P, Mills G, Hansen M, Hayn M, Menon M, Trinh QD, Abdollah F, Sammon JD.

J Urol. 2018 Feb;199(2):424-429. doi: 10.1016/j.juro.2017.10.011. Epub 2017 Oct 10.

PMID:
29030318
37.

Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer.

Abdollah F, Arora S, von Landenberg N, Gild P, Sood A, Dalela D, Trinh QD, Menon M, Rogers C.

BJU Int. 2018 Mar;121(3):345-347. doi: 10.1111/bju.14039. Epub 2017 Oct 18. No abstract available.

38.

Variation in the use of active surveillance for low-risk prostate cancer.

Löppenberg B, Friedlander DF, Krasnova A, Tam A, Leow JJ, Nguyen PL, Barry H, Lipsitz SR, Menon M, Abdollah F, Sammon JD, Sun M, Choueiri TK, Kibel AS, Trinh QD.

Cancer. 2018 Jan 1;124(1):55-64. doi: 10.1002/cncr.30983. Epub 2017 Sep 13.

39.

Robot-Assisted Laparoscopic Repair of Extraperitoneal Ureteral Inguinal Hernia with Mesh Placement.

Pucheril D, Chun B, Dalela D, Abdollah F, Laker SA, Rogers CG.

J Endourol Case Rep. 2017 Jul 1;3(1):97-100. doi: 10.1089/cren.2017.0046. eCollection 2017.

40.

Efficacy of Local Treatment in Prostate Cancer Patients with Clinically Pelvic Lymph Node-positive Disease at Initial Diagnosis.

Seisen T, Vetterlein MW, Karabon P, Jindal T, Sood A, Nocera L, Nguyen PL, Choueiri TK, Trinh QD, Menon M, Abdollah F.

Eur Urol. 2017 Sep 7. pii: S0302-2838(17)30697-8. doi: 10.1016/j.eururo.2017.08.011. [Epub ahead of print]

PMID:
28890245
41.

Editorial Comment.

Dalela D, Abdollah F.

J Urol. 2017 Nov;198(5):1067. doi: 10.1016/j.juro.2017.05.095. Epub 2017 Aug 3. No abstract available.

PMID:
28780289
42.

Racial Disparity in Delivering Definitive Therapy for Intermediate/High-risk Localized Prostate Cancer: The Impact of Facility Features and Socioeconomic Characteristics.

Friedlander DF, Trinh QD, Krasnova A, Lipsitz SR, Sun M, Nguyen PL, Kibel AS, Choueiri TK, Weissman JS, Menon M, Abdollah F.

Eur Urol. 2017 Aug 1. pii: S0302-2838(17)30652-8. doi: 10.1016/j.eururo.2017.07.023. [Epub ahead of print]

PMID:
28778619
43.

Prostate Cancer Screening in Early Medicaid Expansion States.

Sammon JD, Serrell EC, Karabon P, Leow JJ, Abdollah F, Weissman JS, Han PKJ, Hansen M, Menon M, Trinh QD.

J Urol. 2018 Jan;199(1):81-88. doi: 10.1016/j.juro.2017.07.083. Epub 2017 Jul 29.

PMID:
28765069
44.

Emergency Department Utilization in Patients With Neurogenic Bladder: Contemporary Burden and National Trends in Prevalence, Inpatient Admission, and Associated Charges, 2006-2011.

Sood A, Phelps J, Palma-Zamora I, Jindal T, Abdollah F, Vuljaj A, Sammon JD, Trinh QD, Menon M, Atiemo H.

Urology. 2017 Nov;109:74-81. doi: 10.1016/j.urology.2017.07.024. Epub 2017 Jul 26.

PMID:
28755964
45.

Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.

Dalela D, Sun M, Diaz M, Karabon P, Seisen T, Trinh QD, Menon M, Abdollah F.

Eur Urol Focus. 2019 Jan;5(1):77-80. doi: 10.1016/j.euf.2017.04.012. Epub 2017 May 12.

PMID:
28753893
46.

Trends in Prostate-Specific Antigen Screening Since the Implementation of the 2012 US Preventive Services Task Force Recommendations.

Rahbar H, Karabon P, Menon M, Trinh QD, Abdollah F.

Eur Urol Focus. 2018 Dec;4(6):1002-1004. doi: 10.1016/j.euf.2017.02.004. Epub 2017 Feb 22.

PMID:
28753856
47.

Impact of Baseline Characteristics on the Survival Benefit of High-Intensity Local Treatment in Metastatic Urothelial Carcinoma of the Bladder.

Vetterlein MW, Karabon P, Dalela D, Jindal T, Sood A, Seisen T, Trinh QD, Menon M, Abdollah F.

Eur Urol Focus. 2018 Jul;4(4):568-571. doi: 10.1016/j.euf.2016.12.003. Epub 2016 Dec 24.

PMID:
28753834
48.

Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study.

Moschini M, Fossati N, Sood A, Lee JK, Sammon J, Sun M, Pucheril D, Dalela D, Montorsi F, Karnes RJ, Briganti A, Trinh QD, Menon M, Abdollah F.

Eur Urol Focus. 2018 Jan;4(1):68-74. doi: 10.1016/j.euf.2016.06.001. Epub 2016 Jun 14.

PMID:
28753764
49.

Surgical Training in the Robotic Surgery Era: The Importance of Structured Programs.

Abdollah F, Jindal T, Menon M.

Eur Urol Focus. 2017 Feb;3(1):117-118. doi: 10.1016/j.euf.2016.05.007. Epub 2016 Jun 1. No abstract available.

PMID:
28720355
50.

Minimally invasive surgery and its impact on 30-day postoperative complications, unplanned readmissions and mortality.

Sood A, Meyer CP, Abdollah F, Sammon JD, Sun M, Lipsitz SR, Hollis M, Weissman JS, Menon M, Trinh QD.

Br J Surg. 2017 Sep;104(10):1372-1381. doi: 10.1002/bjs.10561. Epub 2017 Jun 20.

PMID:
28632890

Supplemental Content

Loading ...
Support Center